InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Bodenhoff Mads. Director active across 1 company, notably Ascendis Pharma A/S. Cumulatively, 2 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €697k. History available since 8 September 2026. The latest transaction was disclosed on 8 September 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations